292 related articles for article (PubMed ID: 30338715)
41. Glioblastoma Multiforme and Lipid Nanocapsules: A Review.
Aparicio-Blanco J; Torres-Suárez AI
J Biomed Nanotechnol; 2015 Aug; 11(8):1283-311. PubMed ID: 26295134
[TBL] [Abstract][Full Text] [Related]
42. Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide.
Groo AC; Matougui N; Umerska A; Saulnier P
Int J Nanomedicine; 2018; 13():7565-7574. PubMed ID: 30532539
[TBL] [Abstract][Full Text] [Related]
43. Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.
Messaoudi K; Saulnier P; Boesen K; Benoit JP; Lagarce F
Int J Nanomedicine; 2014; 9():1479-90. PubMed ID: 24711698
[TBL] [Abstract][Full Text] [Related]
44. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide.
Saliou B; Thomas O; Lautram N; Clavreul A; Hureaux J; Urban T; Benoit JP; Lagarce F
Eur J Pharm Sci; 2013 Oct; 50(2):172-80. PubMed ID: 23831519
[TBL] [Abstract][Full Text] [Related]
45. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
Karim R; Palazzo C; Evrard B; Piel G
J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
[TBL] [Abstract][Full Text] [Related]
46. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting.
Morille M; Montier T; Legras P; Carmoy N; Brodin P; Pitard B; Benoît JP; Passirani C
Biomaterials; 2010 Jan; 31(2):321-9. PubMed ID: 19800113
[TBL] [Abstract][Full Text] [Related]
47. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
[TBL] [Abstract][Full Text] [Related]
48. Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.
Manaspon C; Nasongkla N; Chaimongkolnukul K; Nittayacharn P; Vejjasilpa K; Kengkoom K; Boongird A; Hongeng S
Pharm Res; 2016 Dec; 33(12):2891-2903. PubMed ID: 27495180
[TBL] [Abstract][Full Text] [Related]
49. Encapsulation in lipid-core nanocapsules overcomes lung cancer cell resistance to tretinoin.
Schultze E; Ourique A; Yurgel VC; Begnini KR; Thurow H; de Leon PM; Campos VF; Dellagostin OA; Guterres SR; Pohlmann AR; Seixas FK; Beck RC; Collares T
Eur J Pharm Biopharm; 2014 May; 87(1):55-63. PubMed ID: 24525073
[TBL] [Abstract][Full Text] [Related]
50. EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro.
Resnier P; David S; Lautram N; Delcroix GJ; Clavreul A; Benoit JP; Passirani C
Int J Pharm; 2013 Oct; 454(2):748-55. PubMed ID: 23583841
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
52. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
53. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
54. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
55. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
56. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
57. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
58. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
[TBL] [Abstract][Full Text] [Related]
59. Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model.
David S; Montier T; Carmoy N; Resnier P; Clavreul A; Mével M; Pitard B; Benoit JP; Passirani C
J Gene Med; 2012 Dec; 14(12):769-75. PubMed ID: 23143656
[TBL] [Abstract][Full Text] [Related]
60. Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix.
Guo Y; Zhong T; Duan XC; Zhang S; Yao X; Yin YF; Huang D; Ren W; Zhang Q; Zhang X
Drug Deliv; 2017 Nov; 24(1):270-277. PubMed ID: 28165798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
